1. Impact of the dairy product structure and protein nature on the proteolysis and amino acid bioaccessiblity during in vitro digestion. (September 2018) Authors: Lorieau, L.; Halabi, A.; Ligneul, A.; Hazart, E.; Dupont, D.; Floury, J. Journal: Food hydrocolloids Issue: Volume 82(2018) Page Start: 399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P1 receptor modulator: Favorable impact of dose up‐titration. (9th January 2014) Authors: Brossard, P.; Scherz, M.; Halabi, A.; Maatouk, H.; Krause, A.; Dingemanse, J. Journal: Journal of clinical pharmacology Issue: Volume 54:Number 2(2014:Feb.) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment. Issue 3 (19th August 2013) Authors: Macha, S.; Mattheus, M.; Halabi, A.; Pinnetti, S.; Woerle, H. J.; Broedl, U. C. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 3(2014:Mar.) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's disease. (25th November 2015) Authors: Rabinovich‐Guilatt, L.; Siegler, K. E.; Schultz, A.; Halabi, A.; Rembratt, A.; Spiegelstein, O. Journal: British journal of clinical pharmacology Issue: Volume 81:Number 2(2016:Feb.) Page Start: 246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗